𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in the molecular recognition of DNA — A step towards therapeutic drug design

✍ Scribed by Arvind M. Kayastha; Prakash Prabhakar; O.P. Malhotra

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
595 KB
Volume
23
Category
Article
ISSN
0307-4412

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Restrained molecular dynamics simulation
Restrained molecular dynamics simulations of HIV-1 protease: The first step in validating a new target for drug design
✍ Alexander L. Perryman; Jung-Hsin Lin; J. Andrew McCammon 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 804 KB

## Abstract To test the anticorrelated relationship that was recently displayed in conventional molecular dynamics (MD) simulations, several different restrained MD simulations on a wild type and on the V82F/I84V drug‐resistant mutant of HIV‐1 protease were performed. This anticorrelated relationsh

The role of DNA–Protein salt bridges in
The role of DNA–Protein salt bridges in molecular recognition: A model study
✍ Raphael Gurlie; Tap Ha Duong; Krystyna Zakrzewska 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 470 KB 👁 2 views

A theoretical study is presented of the influence of salt bridges between cationic side chains and DNA phosphates on DNA conformation and flexibility. The DNA sequence studied is that of the catabolite activator protein binding oligomer from the crystallized complex. The effect of salt bridges is mo

A technique to study molecular recogniti
A technique to study molecular recognition in drug design: Preliminary application of free energy derivatives to inhibition of a malarial cysteine protease
✍ Piotr Cieplak; Peter A. Kollman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

We present molecular dynamics studies on model complexes of inhibitors of a malarial cysteine protease. The initial model for such complexes came from the model building of the protein using its homology with other cysteine proteases and calculations using DOCK to generate new lead compounds. Some o